China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research note issued on Saturday. The firm set a “hold” rating on the stock.

China Pharma Price Performance

Shares of CPHI stock opened at $0.24 on Friday. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.44. The stock’s 50-day moving average price is $0.22 and its 200-day moving average price is $0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.